| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |